Does GLOFITAMAB-GXBM Cause C-reactive protein increased? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of C-reactive protein increased have been filed in association with GLOFITAMAB-GXBM. This represents 1.4% of all adverse event reports for GLOFITAMAB-GXBM.
7
Reports of C-reactive protein increased with GLOFITAMAB-GXBM
1.4%
of all GLOFITAMAB-GXBM reports
1
Deaths
4
Hospitalizations
How Dangerous Is C-reactive protein increased From GLOFITAMAB-GXBM?
Of the 7 reports, 1 (14.3%) resulted in death, 4 (57.1%) required hospitalization.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLOFITAMAB-GXBM. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does GLOFITAMAB-GXBM Cause?
Cytokine release syndrome (107)
Disease progression (68)
Off label use (68)
Death (67)
Pyrexia (45)
No adverse event (28)
Immune effector cell-associated neurotoxicity syndrome (25)
Infection (20)
Pneumonia (14)
Condition aggravated (12)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which GLOFITAMAB-GXBM Alternatives Have Lower C-reactive protein increased Risk?
GLOFITAMAB-GXBM vs GLUCAGON
GLOFITAMAB-GXBM vs GLUCAGON\GLUCAGON\WATER
GLOFITAMAB-GXBM vs GLUCARPIDASE
GLOFITAMAB-GXBM vs GLUCOPHAGE
GLOFITAMAB-GXBM vs GLUCOSAMINE